Lehmann

Germany
|
2022-2024
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Leppert

Italy Spain Switzerland
|
2022-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Temelimab

Liebich

Germany
|
2021
  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

Liira

Finland
|
2021-2023
  • Adults
  • General population
  • Outpatient clinic
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19

HeijenbrokKal

The Netherlands
|
2020
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19

Lindsay

United Kingdom
|
2021
  • Adults
  • Fragile population
  • SARS-CoV-2
  • Post-COVID-19

IAMPOCO

Germany
|
2023-2025
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Immunoadsorption

LoCoDiRe-Dys

Greece
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

InvidiCO

Germany
|
2024-2025
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Vimida

Löffelhardt

Germany
|
2020
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

ISARIC

Brazil Colombia France Gibraltar India Israel Italy Malaysia Norway Portugal Spain Sudan Ukraine United Kingdom
|
2020-2022
  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

ITM Antwerp Mpox Cohort

Belgium
|
2022
  • Adults
  • General population
  • People at high risk of STIs
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox